0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Porcine Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-3J12429
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Porcine Vaccines Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Porcine Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-3J12429
Report
September 2024
Pages:138
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Porcine Vaccines - Market Size

The global market for Porcine Vaccines was estimated to be worth US$ 1345 million in 2023 and is forecast to a readjusted size of US$ 2099.7 million by 2030 with a CAGR of 6.5% during the forecast period 2024-2030

Porcine Vaccines - Market

Porcine Vaccines - Market

Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
The porcine vaccines market is experiencing steady growth due to the increasing demand for improved animal health and the rising prevalence of swine diseases. Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Porcine Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Porcine Vaccines by region & country, by Type, and by Application.
The Porcine Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Porcine Vaccines.
Market Segmentation

Scope of Porcine Vaccines - Market Report

Report Metric Details
Report Name Porcine Vaccines - Market
Forecasted market size in 2030 US$ 2099.7 million
CAGR 6.5%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Government Tender
  • Market Sales
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio, Chopper Biology, WINSUN, Hipra, Ringpu Biology, DHN, CAVAC, Virbac, HVRI, Bioveta
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Porcine Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Porcine Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Porcine Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Porcine Vaccines - Market size in 2030?

Ans: The Porcine Vaccines - Market size in 2030 will be US$ 2099.7 million.

Who are the main players in the Porcine Vaccines - Market report?

Ans: The main players in the Porcine Vaccines - Market are Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio, Chopper Biology, WINSUN, Hipra, Ringpu Biology, DHN, CAVAC, Virbac, HVRI, Bioveta

What are the Application segmentation covered in the Porcine Vaccines - Market report?

Ans: The Applications covered in the Porcine Vaccines - Market report are Government Tender, Market Sales

What are the Type segmentation covered in the Porcine Vaccines - Market report?

Ans: The Types covered in the Porcine Vaccines - Market report are CSF Vaccines, FMD Vaccines, Porcine Circovirus Vaccines, PRRS Vaccines, Other

Recommended Reports

Swine Health Solutions

Animal Vaccine Markets

Vaccine Technology Trends

1 Market Overview
1.1 Porcine Vaccines Product Introduction
1.2 Global Porcine Vaccines Market Size Forecast
1.2.1 Global Porcine Vaccines Sales Value (2019-2030)
1.2.2 Global Porcine Vaccines Sales Volume (2019-2030)
1.2.3 Global Porcine Vaccines Sales Price (2019-2030)
1.3 Porcine Vaccines Market Trends & Drivers
1.3.1 Porcine Vaccines Industry Trends
1.3.2 Porcine Vaccines Market Drivers & Opportunity
1.3.3 Porcine Vaccines Market Challenges
1.3.4 Porcine Vaccines Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Porcine Vaccines Players Revenue Ranking (2023)
2.2 Global Porcine Vaccines Revenue by Company (2019-2024)
2.3 Global Porcine Vaccines Players Sales Volume Ranking (2023)
2.4 Global Porcine Vaccines Sales Volume by Company Players (2019-2024)
2.5 Global Porcine Vaccines Average Price by Company (2019-2024)
2.6 Key Manufacturers Porcine Vaccines Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Porcine Vaccines Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Porcine Vaccines
2.9 Porcine Vaccines Market Competitive Analysis
2.9.1 Porcine Vaccines Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Porcine Vaccines Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Vaccines as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 CSF Vaccines
3.1.2 FMD Vaccines
3.1.3 Porcine Circovirus Vaccines
3.1.4 PRRS Vaccines
3.1.5 Other
3.2 Global Porcine Vaccines Sales Value by Type
3.2.1 Global Porcine Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Porcine Vaccines Sales Value, by Type (2019-2030)
3.2.3 Global Porcine Vaccines Sales Value, by Type (%) (2019-2030)
3.3 Global Porcine Vaccines Sales Volume by Type
3.3.1 Global Porcine Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Porcine Vaccines Sales Volume, by Type (2019-2030)
3.3.3 Global Porcine Vaccines Sales Volume, by Type (%) (2019-2030)
3.4 Global Porcine Vaccines Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Government Tender
4.1.2 Market Sales
4.2 Global Porcine Vaccines Sales Value by Application
4.2.1 Global Porcine Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Porcine Vaccines Sales Value, by Application (2019-2030)
4.2.3 Global Porcine Vaccines Sales Value, by Application (%) (2019-2030)
4.3 Global Porcine Vaccines Sales Volume by Application
4.3.1 Global Porcine Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Porcine Vaccines Sales Volume, by Application (2019-2030)
4.3.3 Global Porcine Vaccines Sales Volume, by Application (%) (2019-2030)
4.4 Global Porcine Vaccines Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Porcine Vaccines Sales Value by Region
5.1.1 Global Porcine Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Porcine Vaccines Sales Value by Region (2019-2024)
5.1.3 Global Porcine Vaccines Sales Value by Region (2025-2030)
5.1.4 Global Porcine Vaccines Sales Value by Region (%), (2019-2030)
5.2 Global Porcine Vaccines Sales Volume by Region
5.2.1 Global Porcine Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Porcine Vaccines Sales Volume by Region (2019-2024)
5.2.3 Global Porcine Vaccines Sales Volume by Region (2025-2030)
5.2.4 Global Porcine Vaccines Sales Volume by Region (%), (2019-2030)
5.3 Global Porcine Vaccines Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Porcine Vaccines Sales Value, 2019-2030
5.4.2 North America Porcine Vaccines Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Porcine Vaccines Sales Value, 2019-2030
5.5.2 Europe Porcine Vaccines Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Porcine Vaccines Sales Value, 2019-2030
5.6.2 Asia Pacific Porcine Vaccines Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Porcine Vaccines Sales Value, 2019-2030
5.7.2 South America Porcine Vaccines Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Porcine Vaccines Sales Value, 2019-2030
5.8.2 Middle East & Africa Porcine Vaccines Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Porcine Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Porcine Vaccines Sales Value
6.2.1 Key Countries/Regions Porcine Vaccines Sales Value, 2019-2030
6.2.2 Key Countries/Regions Porcine Vaccines Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Porcine Vaccines Sales Value, 2019-2030
6.3.2 United States Porcine Vaccines Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Porcine Vaccines Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Porcine Vaccines Sales Value, 2019-2030
6.4.2 Europe Porcine Vaccines Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Porcine Vaccines Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Porcine Vaccines Sales Value, 2019-2030
6.5.2 China Porcine Vaccines Sales Value by Type (%), 2023 VS 2030
6.5.3 China Porcine Vaccines Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Porcine Vaccines Sales Value, 2019-2030
6.6.2 Japan Porcine Vaccines Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Porcine Vaccines Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Porcine Vaccines Sales Value, 2019-2030
6.7.2 South Korea Porcine Vaccines Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Porcine Vaccines Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Porcine Vaccines Sales Value, 2019-2030
6.8.2 Southeast Asia Porcine Vaccines Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Porcine Vaccines Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Porcine Vaccines Sales Value, 2019-2030
6.9.2 India Porcine Vaccines Sales Value by Type (%), 2023 VS 2030
6.9.3 India Porcine Vaccines Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merck Porcine Vaccines Product Offerings
7.1.5 Merck Recent Development
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Information
7.2.2 Boehringer Ingelheim Introduction and Business Overview
7.2.3 Boehringer Ingelheim Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Boehringer Ingelheim Porcine Vaccines Product Offerings
7.2.5 Boehringer Ingelheim Recent Development
7.3 Jinyu Bio-Technology
7.3.1 Jinyu Bio-Technology Company Information
7.3.2 Jinyu Bio-Technology Introduction and Business Overview
7.3.3 Jinyu Bio-Technology Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Jinyu Bio-Technology Porcine Vaccines Product Offerings
7.3.5 Jinyu Bio-Technology Recent Development
7.4 CAHIC
7.4.1 CAHIC Company Information
7.4.2 CAHIC Introduction and Business Overview
7.4.3 CAHIC Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.4.4 CAHIC Porcine Vaccines Product Offerings
7.4.5 CAHIC Recent Development
7.5 Tecon
7.5.1 Tecon Company Information
7.5.2 Tecon Introduction and Business Overview
7.5.3 Tecon Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Tecon Porcine Vaccines Product Offerings
7.5.5 Tecon Recent Development
7.6 Zoetis
7.6.1 Zoetis Company Information
7.6.2 Zoetis Introduction and Business Overview
7.6.3 Zoetis Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Zoetis Porcine Vaccines Product Offerings
7.6.5 Zoetis Recent Development
7.7 Ceva
7.7.1 Ceva Company Information
7.7.2 Ceva Introduction and Business Overview
7.7.3 Ceva Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Ceva Porcine Vaccines Product Offerings
7.7.5 Ceva Recent Development
7.8 Hile Bio
7.8.1 Hile Bio Company Information
7.8.2 Hile Bio Introduction and Business Overview
7.8.3 Hile Bio Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Hile Bio Porcine Vaccines Product Offerings
7.8.5 Hile Bio Recent Development
7.9 Chopper Biology
7.9.1 Chopper Biology Company Information
7.9.2 Chopper Biology Introduction and Business Overview
7.9.3 Chopper Biology Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Chopper Biology Porcine Vaccines Product Offerings
7.9.5 Chopper Biology Recent Development
7.10 WINSUN
7.10.1 WINSUN Company Information
7.10.2 WINSUN Introduction and Business Overview
7.10.3 WINSUN Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.10.4 WINSUN Porcine Vaccines Product Offerings
7.10.5 WINSUN Recent Development
7.11 Hipra
7.11.1 Hipra Company Information
7.11.2 Hipra Introduction and Business Overview
7.11.3 Hipra Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Hipra Porcine Vaccines Product Offerings
7.11.5 Hipra Recent Development
7.12 Ringpu Biology
7.12.1 Ringpu Biology Company Information
7.12.2 Ringpu Biology Introduction and Business Overview
7.12.3 Ringpu Biology Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Ringpu Biology Porcine Vaccines Product Offerings
7.12.5 Ringpu Biology Recent Development
7.13 DHN
7.13.1 DHN Company Information
7.13.2 DHN Introduction and Business Overview
7.13.3 DHN Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.13.4 DHN Porcine Vaccines Product Offerings
7.13.5 DHN Recent Development
7.14 CAVAC
7.14.1 CAVAC Company Information
7.14.2 CAVAC Introduction and Business Overview
7.14.3 CAVAC Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.14.4 CAVAC Porcine Vaccines Product Offerings
7.14.5 CAVAC Recent Development
7.15 Virbac
7.15.1 Virbac Company Information
7.15.2 Virbac Introduction and Business Overview
7.15.3 Virbac Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Virbac Porcine Vaccines Product Offerings
7.15.5 Virbac Recent Development
7.16 HVRI
7.16.1 HVRI Company Information
7.16.2 HVRI Introduction and Business Overview
7.16.3 HVRI Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.16.4 HVRI Porcine Vaccines Product Offerings
7.16.5 HVRI Recent Development
7.17 Bioveta
7.17.1 Bioveta Company Information
7.17.2 Bioveta Introduction and Business Overview
7.17.3 Bioveta Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Bioveta Porcine Vaccines Product Offerings
7.17.5 Bioveta Recent Development
8 Industry Chain Analysis
8.1 Porcine Vaccines Industrial Chain
8.2 Porcine Vaccines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Porcine Vaccines Sales Model
8.5.2 Sales Channel
8.5.3 Porcine Vaccines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Porcine Vaccines Market Trends
    Table 2. Porcine Vaccines Market Drivers & Opportunity
    Table 3. Porcine Vaccines Market Challenges
    Table 4. Porcine Vaccines Market Restraints
    Table 5. Global Porcine Vaccines Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Porcine Vaccines Revenue Market Share by Company (2019-2024)
    Table 7. Global Porcine Vaccines Sales Volume by Company (2019-2024) & (M Units)
    Table 8. Global Porcine Vaccines Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Porcine Vaccines Price by Company (2019-2024) & (USD/K Unit)
    Table 10. Key Manufacturers Porcine Vaccines Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Porcine Vaccines Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Porcine Vaccines
    Table 13. Global Porcine Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Vaccines as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Porcine Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Porcine Vaccines Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Porcine Vaccines Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Porcine Vaccines Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Porcine Vaccines Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Porcine Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (M Units)
    Table 22. Global Porcine Vaccines Sales Volume by Type (2019-2024) & (M Units)
    Table 23. Global Porcine Vaccines Sales Volume by Type (2025-2030) & (M Units)
    Table 24. Global Porcine Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Porcine Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Porcine Vaccines Price by Type (2019-2024) & (USD/K Unit)
    Table 27. Global Porcine Vaccines Price by Type (2025-2030) & (USD/K Unit)
    Table 28. Global Porcine Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Porcine Vaccines Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Porcine Vaccines Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Porcine Vaccines Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Porcine Vaccines Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Porcine Vaccines Sales Volume by Application: 2019 VS 2023 VS 2030 (M Units)
    Table 34. Global Porcine Vaccines Sales Volume by Application (2019-2024) & (M Units)
    Table 35. Global Porcine Vaccines Sales Volume by Application (2025-2030) & (M Units)
    Table 36. Global Porcine Vaccines Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Porcine Vaccines Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Porcine Vaccines Price by Application (2019-2024) & (USD/K Unit)
    Table 39. Global Porcine Vaccines Price by Application (2025-2030) & (USD/K Unit)
    Table 40. Global Porcine Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Porcine Vaccines Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Porcine Vaccines Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Porcine Vaccines Sales Value by Region (2019-2024) & (%)
    Table 44. Global Porcine Vaccines Sales Value by Region (2025-2030) & (%)
    Table 45. Global Porcine Vaccines Sales Volume by Region (M Units): 2019 VS 2023 VS 2030
    Table 46. Global Porcine Vaccines Sales Volume by Region (2019-2024) & (M Units)
    Table 47. Global Porcine Vaccines Sales Volume by Region (2025-2030) & (M Units)
    Table 48. Global Porcine Vaccines Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Porcine Vaccines Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Porcine Vaccines Average Price by Region (2019-2024) & (USD/K Unit)
    Table 51. Global Porcine Vaccines Average Price by Region (2025-2030) & (USD/K Unit)
    Table 52. Key Countries/Regions Porcine Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Porcine Vaccines Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Porcine Vaccines Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Porcine Vaccines Sales Volume, (2019-2024) & (M Units)
    Table 56. Key Countries/Regions Porcine Vaccines Sales Volume, (2025-2030) & (M Units)
    Table 57. Merck Company Information
    Table 58. Merck Introduction and Business Overview
    Table 59. Merck Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 60. Merck Porcine Vaccines Product Offerings
    Table 61. Merck Recent Development
    Table 62. Boehringer Ingelheim Company Information
    Table 63. Boehringer Ingelheim Introduction and Business Overview
    Table 64. Boehringer Ingelheim Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 65. Boehringer Ingelheim Porcine Vaccines Product Offerings
    Table 66. Boehringer Ingelheim Recent Development
    Table 67. Jinyu Bio-Technology Company Information
    Table 68. Jinyu Bio-Technology Introduction and Business Overview
    Table 69. Jinyu Bio-Technology Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 70. Jinyu Bio-Technology Porcine Vaccines Product Offerings
    Table 71. Jinyu Bio-Technology Recent Development
    Table 72. CAHIC Company Information
    Table 73. CAHIC Introduction and Business Overview
    Table 74. CAHIC Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 75. CAHIC Porcine Vaccines Product Offerings
    Table 76. CAHIC Recent Development
    Table 77. Tecon Company Information
    Table 78. Tecon Introduction and Business Overview
    Table 79. Tecon Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 80. Tecon Porcine Vaccines Product Offerings
    Table 81. Tecon Recent Development
    Table 82. Zoetis Company Information
    Table 83. Zoetis Introduction and Business Overview
    Table 84. Zoetis Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 85. Zoetis Porcine Vaccines Product Offerings
    Table 86. Zoetis Recent Development
    Table 87. Ceva Company Information
    Table 88. Ceva Introduction and Business Overview
    Table 89. Ceva Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 90. Ceva Porcine Vaccines Product Offerings
    Table 91. Ceva Recent Development
    Table 92. Hile Bio Company Information
    Table 93. Hile Bio Introduction and Business Overview
    Table 94. Hile Bio Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 95. Hile Bio Porcine Vaccines Product Offerings
    Table 96. Hile Bio Recent Development
    Table 97. Chopper Biology Company Information
    Table 98. Chopper Biology Introduction and Business Overview
    Table 99. Chopper Biology Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 100. Chopper Biology Porcine Vaccines Product Offerings
    Table 101. Chopper Biology Recent Development
    Table 102. WINSUN Company Information
    Table 103. WINSUN Introduction and Business Overview
    Table 104. WINSUN Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 105. WINSUN Porcine Vaccines Product Offerings
    Table 106. WINSUN Recent Development
    Table 107. Hipra Company Information
    Table 108. Hipra Introduction and Business Overview
    Table 109. Hipra Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 110. Hipra Porcine Vaccines Product Offerings
    Table 111. Hipra Recent Development
    Table 112. Ringpu Biology Company Information
    Table 113. Ringpu Biology Introduction and Business Overview
    Table 114. Ringpu Biology Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 115. Ringpu Biology Porcine Vaccines Product Offerings
    Table 116. Ringpu Biology Recent Development
    Table 117. DHN Company Information
    Table 118. DHN Introduction and Business Overview
    Table 119. DHN Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 120. DHN Porcine Vaccines Product Offerings
    Table 121. DHN Recent Development
    Table 122. CAVAC Company Information
    Table 123. CAVAC Introduction and Business Overview
    Table 124. CAVAC Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 125. CAVAC Porcine Vaccines Product Offerings
    Table 126. CAVAC Recent Development
    Table 127. Virbac Company Information
    Table 128. Virbac Introduction and Business Overview
    Table 129. Virbac Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 130. Virbac Porcine Vaccines Product Offerings
    Table 131. Virbac Recent Development
    Table 132. HVRI Company Information
    Table 133. HVRI Introduction and Business Overview
    Table 134. HVRI Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 135. HVRI Porcine Vaccines Product Offerings
    Table 136. HVRI Recent Development
    Table 137. Bioveta Company Information
    Table 138. Bioveta Introduction and Business Overview
    Table 139. Bioveta Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 140. Bioveta Porcine Vaccines Product Offerings
    Table 141. Bioveta Recent Development
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Porcine Vaccines Downstream Customers
    Table 145. Porcine Vaccines Distributors List
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Porcine Vaccines Product Picture
    Figure 2. Global Porcine Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Porcine Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Porcine Vaccines Sales Volume (2019-2030) & (M Units)
    Figure 5. Global Porcine Vaccines Sales Price (2019-2030) & (USD/K Unit)
    Figure 6. Porcine Vaccines Report Years Considered
    Figure 7. Global Porcine Vaccines Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Porcine Vaccines Players Sales Volume Ranking (2023) & (M Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Porcine Vaccines Revenue in 2023
    Figure 10. Porcine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. CSF Vaccines Picture
    Figure 12. FMD Vaccines Picture
    Figure 13. Porcine Circovirus Vaccines Picture
    Figure 14. PRRS Vaccines Picture
    Figure 15. Other Picture
    Figure 16. Global Porcine Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Porcine Vaccines Sales Value Market Share by Type, 2023 & 2030
    Figure 18. Global Porcine Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (M Units)
    Figure 19. Global Porcine Vaccines Sales Volume Market Share by Type, 2023 & 2030
    Figure 20. Global Porcine Vaccines Price by Type (2019-2030) & (USD/K Unit)
    Figure 21. Product Picture of Government Tender
    Figure 22. Product Picture of Market Sales
    Figure 23. Global Porcine Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Porcine Vaccines Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Porcine Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (M Units)
    Figure 26. Global Porcine Vaccines Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Porcine Vaccines Price by Application (2019-2030) & (USD/K Unit)
    Figure 28. North America Porcine Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Porcine Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Porcine Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Porcine Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Porcine Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Porcine Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Porcine Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Porcine Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Porcine Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Porcine Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Porcine Vaccines Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Porcine Vaccines Sales Volume (%), (2019-2030)
    Figure 40. United States Porcine Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Porcine Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Porcine Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Porcine Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Porcine Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Porcine Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Porcine Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Porcine Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Porcine Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Porcine Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Porcine Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Porcine Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Porcine Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Porcine Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Porcine Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Porcine Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Porcine Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Porcine Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Porcine Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Porcine Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Porcine Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 61. Porcine Vaccines Industrial Chain
    Figure 62. Porcine Vaccines Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS